Understanding anti-leukemia responses to donor lymphocyte infusion

Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachireddy, Pavan, Wu, Catherine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/
https://www.ncbi.nlm.nih.gov/pubmed/25340010
http://dx.doi.org/10.4161/onci.28187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/
https://www.ncbi.nlm.nih.gov/pubmed/25340010
http://dx.doi.org/10.4161/onci.28187

Ejemplares similares